Results 121 to 130 of about 601,324 (309)

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Changes of Market Structure and Competition in the Croatian (Non)Life Insurance Industry

open access: yesThe business review, Cambridge, 2011
Until the nineties of the last century, the Croatian insurance market used to be highly concentrated. However, with the entrance of foreign capital and private investors, market structure and level of competition significantly changed. From former almost monopolistic situation with only one (or a few) state owned insurance companies operating on it ...
Pervan, Maja   +2 more
openaire   +2 more sources

Productivity and Technical Efficiency in the Italian Insurance Industry [PDF]

open access: yes
The purpose of this paper is to partially fill the gap in the existing literature by conducting an analysis of technical efficiency and productivity growth in the Italian insurance industry.
Giuseppe Turchetti, J. David Cummins
core  

An Analysis of Current Healthcare Proposals: Obama and McCain [PDF]

open access: yes, 2008
The healthcare system of the U.S. is broken. The next opportunity for overwhelming healthcare system reform will be when the next president takes office.
Terrell, Dan
core   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló   +5 more
wiley   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić   +4 more
wiley   +1 more source

Credibility Distribution Estimation with Weighted or Grouped Observations

open access: yesRisks
In non-life insurance practice, actuaries are often faced with the challenge of predicting the number of claims and claim amounts to be incurred at any given time, which serve to implement fair pricing and reserves given the nature of the risk.
Georgios Pitselis
doaj   +1 more source

The Future of Colorado Health Care [PDF]

open access: yes, 2009
A preview to the forthcoming report on an analysis of health care reform and the impact on Colorado's economy. The study is being conducted by Len Nichols, PhD, of the New America Foundation and Henry Sobanet on behalf of the University of Denver's ...
Henry Sobanet, Len Nichols
core  

Low‐intervention clinical trials in Spain: Do they progress?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza   +4 more
wiley   +1 more source

LIBERALISATION, MARKET CONCENTRATION AND PERFORMANCE IN THE NON-LIFE INSURANCE INDUSTRY OF EX-YUGOSLAVIA

open access: yesEkonomska misao i praksa, 2011
The aim of this paper is to examine market structure, liberalisation and performance relationship for the non-life insurance industry in the ex-Yugoslavia region. We use the country-specific fixed effects models for panel data allowing each cross-sectional unit to have a different intercept term serving as an unobserved random variable that is ...
Njegomir, Vladimir   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy